• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性溶血性贫血。

Congenital Hemolytic Anemia.

机构信息

Department of Pediatrics, Division of Pediatric Hematology/Oncology, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Mail Code CDRCP, Portland, OR 97239, USA.

出版信息

Med Clin North Am. 2017 Mar;101(2):361-374. doi: 10.1016/j.mcna.2016.09.008. Epub 2016 Dec 8.

DOI:10.1016/j.mcna.2016.09.008
PMID:28189176
Abstract

Red blood cell (RBC) destruction can be secondary to intrinsic disorders of the RBC or to extrinsic causes. In the congenital hemolytic anemias, intrinsic RBC enzyme, RBC membrane, and hemoglobin disorders result in hemolysis. The typical clinical presentation is a patient with pallor, anemia, jaundice, and often splenomegaly. The laboratory features include anemia, hyperbilirubinemia, and reticulocytosis. For some congenital hemolytic anemias, splenectomy is curative. However, in other diseases, avoidance of drugs and toxins is the best therapy. Supportive care with transfusions are also mainstays of therapy. Chronic hemolysis often results in the formation of gallstones, and cholecystectomy is often indicated.

摘要

红细胞(RBC)破坏可继发于 RBC 的内在紊乱或外在原因。在先天性溶血性贫血中,RBC 酶、RBC 膜和血红蛋白内在紊乱导致溶血。典型临床表现为苍白、贫血、黄疸,常伴有脾肿大。实验室特征包括贫血、高胆红素血症和网织红细胞增多。对于一些先天性溶血性贫血,脾切除术是治愈性的。然而,在其他疾病中,避免药物和毒素是最佳治疗方法。输血等支持性治疗也是治疗的基础。慢性溶血常导致胆石形成,常需要行胆囊切除术。

相似文献

1
Congenital Hemolytic Anemia.先天性溶血性贫血。
Med Clin North Am. 2017 Mar;101(2):361-374. doi: 10.1016/j.mcna.2016.09.008. Epub 2016 Dec 8.
2
Red Blood Cell Enzyme Disorders.红细胞酶紊乱
Pediatr Clin North Am. 2018 Jun;65(3):579-595. doi: 10.1016/j.pcl.2018.02.005.
3
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.丙酮酸激酶缺乏症的临床谱:来自丙酮酸激酶缺乏症自然史研究的数据。
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.
4
Epidemiological Study of Hereditary Hemolytic Anemia in the Korean Pediatric Population during 1997-2016: a Nationwide Retrospective Cohort Study.1997-2016 年韩国儿科人群遗传性溶血性贫血的流行病学研究:一项全国性回顾性队列研究。
J Korean Med Sci. 2020 Aug 24;35(33):e279. doi: 10.3346/jkms.2020.35.e279.
5
Management of pyruvate kinase deficiency in children and adults.儿童和成人丙酮酸激酶缺乏症的管理。
Blood. 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945.
6
How we manage patients with pyruvate kinase deficiency.丙酮酸激酶缺乏症患者的管理方法。
Br J Haematol. 2019 Mar;184(5):721-734. doi: 10.1111/bjh.15758. Epub 2019 Jan 25.
7
[How I do in front of an hemolytic anemia of unknown etiology?].面对病因不明的溶血性贫血我该怎么做?
Ann Biol Clin (Paris). 2018 Oct 1;76(5):493-503. doi: 10.1684/abc.2018.1381.
8
Laboratory Approach to Hemolytic Anemia.溶血性贫血的实验室检查方法。
Indian J Pediatr. 2020 Jan;87(1):66-74. doi: 10.1007/s12098-019-03119-8. Epub 2019 Dec 10.
9
[Congenital hemolytic anemia].[先天性溶血性贫血]
Schweiz Med Wochenschr. 1971 Feb 13;101(6):187-90.
10
Molecular heterogeneity of pyruvate kinase deficiency.丙酮酸激酶缺乏症的分子异质性。
Haematologica. 2020 Sep 1;105(9):2218-2228. doi: 10.3324/haematol.2019.241141.

引用本文的文献

1
Serine Hydroxymethyltransferase 2 Deficiency in the Hematopoietic System Disrupts Erythropoiesis and Induces Anemia in Murine Models.造血系统丝氨酸羟甲基转移酶 2 缺乏症破坏红细胞生成并诱导小鼠模型贫血。
Int J Mol Sci. 2024 Oct 15;25(20):11072. doi: 10.3390/ijms252011072.
2
Catalase, Glutathione Peroxidase, and Peroxiredoxin 2 in Erythrocyte Cytosol and Membrane in Hereditary Spherocytosis, Sickle Cell Disease, and β-Thalassemia.遗传性球形红细胞增多症、镰状细胞病和β地中海贫血患者红细胞胞质溶胶和膜中的过氧化氢酶、谷胱甘肽过氧化物酶和过氧化物还原酶2
Antioxidants (Basel). 2024 May 22;13(6):629. doi: 10.3390/antiox13060629.
3
Current Status of Molecular Diagnosis of Hereditary Hemolytic Anemia in Korea.
韩国遗传性溶血性贫血的分子诊断现状。
J Korean Med Sci. 2024 May 13;39(18):e162. doi: 10.3346/jkms.2024.39.e162.
4
Reticulocyte Antioxidant Enzymes mRNA Levels versus Reticulocyte Maturity Indices in Hereditary Spherocytosis, β-Thalassemia and Sickle Cell Disease.遗传性球形红细胞增多症、β-地中海贫血和镰状细胞病中网织红细胞抗氧化酶 mRNA 水平与网织红细胞成熟指数的比较。
Int J Mol Sci. 2024 Feb 10;25(4):2159. doi: 10.3390/ijms25042159.
5
Case of Congenital Hemolytic Anemia with and Variants.伴有[具体基因名称1]和[具体基因名称2]变异的先天性溶血性贫血病例。 (你原文中“and Variants”部分表述不完整,这里只是按照格式翻译示例补充完整后的译文)
Children (Basel). 2023 Sep 25;10(10):1600. doi: 10.3390/children10101600.
6
Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias.中药疗法对台湾遗传性溶血性贫血患者全因死亡、糖尿病相关死亡和心血管疾病相关死亡风险的影响。
Front Pharmacol. 2022 May 30;13:891729. doi: 10.3389/fphar.2022.891729. eCollection 2022.
7
Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia.韩国遗传性溶血性贫血诊断临床实践指南。
Blood Res. 2022 Jun 30;57(2):86-94. doi: 10.5045/br.2022.2021224. Epub 2022 May 20.
8
The diagnostic protocol for hereditary spherocytosis-2021 update.遗传性球形红细胞增多症-2021 年诊断方案更新。
J Clin Lab Anal. 2021 Dec;35(12):e24034. doi: 10.1002/jcla.24034. Epub 2021 Oct 24.
9
Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.新生儿期先天性溶血性贫血的严重表现:诊断与治疗问题
Diagnostics (Basel). 2021 Aug 26;11(9):1549. doi: 10.3390/diagnostics11091549.
10
Epidemiological Study of Hereditary Hemolytic Anemia in the Korean Pediatric Population during 1997-2016: a Nationwide Retrospective Cohort Study.1997-2016 年韩国儿科人群遗传性溶血性贫血的流行病学研究:一项全国性回顾性队列研究。
J Korean Med Sci. 2020 Aug 24;35(33):e279. doi: 10.3346/jkms.2020.35.e279.